[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page No. 3 PART I. FINANCIAL INFORMATION 4 Item 1. Condensed Consolidated Financial Statements 4 Condensed Consolidated Balance Sheets as of June 30, 2011 (unaudited) and December 31, 2010 4 Condensed Consolidated Statements of Income and Other Comprehensive Income for the Six Months Ended June 30, 2011 and 2010 (unaudited) 5] [CERTIFICATION I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SKYSTAR BIO-PHARMACEUTICAL COMPANY; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SKYSTAR BIO-PHARMACEUTICAL COMPANY; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Weibing Lu] [CERTIFICATION (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Bing Mei Bing Mei Chief Financial Officer (Principal Accounting and Financial Officer)]